Clinical Trials Browser

Plasmacytoma × Immunotherapy, Adoptive × 90 days × Clear all

NCT06429150 2026-04-24

Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma

Phase 1/2 Recruiting

Multiple Myeloma, Plasmacytoma